References
- Qizilbash AH. Gastritis cystica and carcinoma arising in old gastrojejunostomy stoma. Can Med Assoc J 1975;112:1432–3.
- Franzin G, Novelli P. Gastritis cystica profunda. Histopathology 1981;5:535–47.
- Littler ER, Gleibermann E. Gastritis cystica polyposa (gastric mucosal prolapse at gastroenterostomy site, with cystic and infiltrative epithelial hyperplasia). Cancer 1972;29:205–9.
- Honoré LH, Lewis AS, O’Hara KE. Gastritic glandularis et cystica profunda: a report of three cases with discussion of etiology and pathogenesis. Dig Dis Sci 1979;24:48–52.
- Fonde EC, Rodning CB. Gastritis cystica profunda. Am J Gastroenterol 1986;81:459–64.
- Iwanaga T, Koyama H, Takahashi Y, Taniguchi H, Wada A. Diffuse submucosal cysts and carcinoma of the stomach. Cancer 1975;36:606–14.
- Kastan MB, Onyekwere O, Sidransky D, Volelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51: 6304–11.
- Vogelstein B, Kinzler KW. P53 function and dysfunction. Cell 1992;70:523–6.
- Hibi K, Mitomi H, Koizumi W, Tanabe S, Saigenji K, Okayasu I. Enhanced cellular proliferation and p53 accumulation in gastric mucosa chronically infected with Helicobacter pylori. Am J Clin Pathol 1997;108:26–34.
- Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvaifler NJ. Apoptosis in rheumatoid arthritis. p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 1996;149:2143–51.
- Cunningham J, Lust JA, Schaid DJ, Bren GD, Carpenter HA, Rizza E, et al. Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res 1992;52:1974–80.
- Iggo R, Gatter K, Barteck J, Lane D, Harris AL. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990;335: 675–9.
- El-Deiry WS, Harper JW, O’Connor PM, Velculescu VE, Canman CE, Jackman J, et al. WAF 1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54: 1169–74.
- Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, et al. P53-independent expression of p21CIP1 in muscle and other terminally differentiating cells. Science 1995;267:1024–7.
- Marchetti A, Doglioni C, Barbareschi M, Buttitta F, Pellegrini S, Bertacca G, et al. P21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene 1996;12:1319–24.
- El-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, et al. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 1995;55: 2910–9.
- Dixon MF, Genta RM, Yardley JH, Correa P, the participants in the international workshop on the histopathology of gastritis. Classification and grading of gastritis, Houston 1994: the updated Sydney system. Am J Surg Pathol 1996;20: 1161–81.
- Scotti TM. Simian gastropathy with submucosal glands and cysts: gastritis glandularis or cystica profunda? Arch Pathol 1973;96:403–8.
- Allen JR, Norback DH. Polychlorinated biphenyl- and triphenylinduced gastric mucosal hyperplasia in primates. Science 1973;179:498–9.
- Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133: 1710–5.
- Kang M, Mitomi H, Sada M, Tokumitsu Y, Takahashi Y, Igarashi M, et al. Ki-67, p53, and Bcl-2 expression of serrated adenomas of the colon. Am J Surg Pathol 1997;21:417–23.
- Yasui W, Akama Y, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F, et al. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity. J Pathol 1996;180:122–8.